Localization of the third heparin-binding site in the human complement regulator factor H1

被引:55
作者
Ormsby, RJ [1 ]
Jokiranta, TS
Duthy, TG
Griggs, KA
Sadlon, TA
Giannakis, E
Gordon, DL
机构
[1] Univ S Australia, Dept Microbiol & Infect Dis, Flinders Med Ctr, Adelaide, SA, Australia
[2] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland
[3] Univ Helsinki, HUSLAB, Helsinki, Finland
[4] Univ Helsinki Hosp, Helsinki, Finland
基金
芬兰科学院; 英国医学研究理事会;
关键词
complement; alternative pathway; heparin-binding;
D O I
10.1016/j.molimm.2005.09.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complement factor H (fH) plays a pivotal role in regulating the alternative pathway, allowing complement activation to proceed on foreign surfaces, whilst protecting surrounding host cell surfaces from complement-mediated damage. Host cell recognition is mediated by polyanions such as sialic acid and glycosaminoglycans (GAGs), which promote a high affinity interaction between fH and C3b deposited on host cell surfaces. Factor H is composed of 20 short consensus repeats (SCRs); two heparin-binding sites have been identified within SCR 7 and SCR 20 and a third site is thought to exist within or near SCR 13. Using an extensive series of recombinant fH fragments and heparin affinity chromatography, we have localized the third heparin-binding domain to SCR 9. A recombinant fH fragment containing both SCR 7 and SCR 9 exhibited higher affinity for heparin than SCR 7 alone, suggesting that the individual heparin-binding sites interact simultaneously with heparin to create a higher avidity interaction. Recombinant fragments containing SCR 9 bound to endothelial cells, indicating that this domain is capable of interacting with polyanions within a physiologically relevant environment. In addition, the three heparin-binding sites exhibited differences in their specificity for certain GAGs, suggesting that the individual binding domains may possess separate GAG recognition functions. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1624 / 1632
页数:9
相关论文
共 44 条
[1]  
Blackmore TK, 1996, J IMMUNOL, V157, P5422
[2]  
Blackmore TK, 1998, J IMMUNOL, V160, P3342
[3]  
BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
[4]  
BROOIMANS RA, 1990, J IMMUNOL, V144, P3835
[5]   Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis:: Report and genetic analysis of 16 cases [J].
Dragon-Durey, MA ;
Frémeaux-Bacchi, V ;
Loirat, C ;
Blouin, J ;
Niaudet, P ;
Deschenes, G ;
Coppo, P ;
Fridman, WH ;
Weiss, L .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03) :787-795
[6]   The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15 [J].
Duthy, TG ;
Ormsby, RJ ;
Giannakis, E ;
Ogunniyi, AD ;
Stroeher, UH ;
Paton, JC ;
Gordon, DL .
INFECTION AND IMMUNITY, 2002, 70 (10) :5604-5611
[7]   Heparin structure and interactions with basic fibroblast growth factor [J].
Faham, S ;
Hileman, RE ;
Fromm, JR ;
Linhardt, RJ ;
Rees, DC .
SCIENCE, 1996, 271 (5252) :1116-1120
[8]   COMPETITION FOR BINDING-SITES ON C3B BY CR-1, CR-2, MCP, FACTOR-B AND FACTOR-H [J].
FARRIES, TC ;
SEYA, T ;
HARRISON, RA ;
ATKINSON, JP .
COMPLEMENT AND INFLAMMATION, 1990, 7 (01) :30-41
[9]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY WITH RABBIT ERYTHROCYTES BY CIRCUMVENTION OF REGULATORY ACTION OF ENDOGENOUS CONTROL PROTEINS [J].
FEARON, DT ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (01) :22-33
[10]   REGULATION BY MEMBRANE SIALIC-ACID OF BETA-1H-DEPENDENT DECAY-DISSOCIATION OF AMPLIFICATION C3 CONVERTASE OF ALTERNATIVE COMPLEMENT PATHWAY [J].
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :1971-1975